Bioscience
- اسفند- 1396 -5 اسفند
Upcoming Conversation With An Expert: Preparing For More Phase 2 Data From Selecta Biosciences
Summary We will be interviewing an academic rheumatologist familiar with SEL-212 (Selecta) and Horizon’s Krystexxa and has experience in managing chronic refractory gout. This call…
-- بیشتر بخوانید -- - بهمن- 1396 -4 بهمندیگر
Gene Therapy Pioneer James Wilson Joins RSRT Consortium; Resigns from Advisory Role at IPO-Bound Solid Biosciences
James M. Wilson, M.D., Ph.D., has joined the Gene Therapy Consortium of the Rett Syndrome Research Trust (RSRT), the Trust said today. The announcement came…
-- بیشتر بخوانید -- - دی- 1396 -26 دیدیگر
ARMO BioSciences Proposes Terms For $100 U.S. IPO
Summary ARMO BioSciences intends to raise $100 million in a U.S. IPO. The firm is developing a promising pipeline of immuno-based treatments for some of…
-- بیشتر بخوانید -- - 15 دیدیگر
Neurocrine Biosciences: Continued Upside In 2018
Summary Shares have risen by 55% since initially presenting the idea to readers. I recap the bullish thesis and remind readers of the untapped potential…
-- بیشتر بخوانید -- - 3 دیدیگر
توسعه دهنده ایمونوتراپی سرطان فایل هایBioSciences برای ذخیره-$86.25M IPO
Cancer Immunotherapy Developer Armo BioSciences Files for Up-to-$86.25M IPO Armo BioSciences, a late-stage developer of cancer immunotherapies, will seek to raise up to $86.25 million…
-- بیشتر بخوانید -- - آذر- 1396 -28 آذردیگر
نوروکرین بیولوژیکی
Neurocrine Biosciences: Continued Upside In 2018 Summary Shares have risen by 55% since initially presenting the idea to readers. I recap the bullish thesis and…
-- بیشتر بخوانید -- - 20 آذر
تولید عصاره اسپیرولینا
Lumen raises $13M for spirulina extract eattle, WA-based Lumen Bioscience, a synthetic biotechnology company developing a novel bio-based product development platform, has raised $13 million…
-- بیشتر بخوانید -- - 3 آذردیگر
CRISPR/Cas3 Platform Developer Locus Biosciences Raises $19M in Series A Financing
Locus Biosciences, developer of a next-generation CRISPR/Cas platform for precision antimicrobials, has closed $19 million in Series A funding designed to fund the company through…
-- بیشتر بخوانید -- - آبان- 1396 -19 آباندیگر
بیماری های عفونی
Infectious diseases: CTRL + ALT + Delete Gene editing is revolutionizing the bioscience research landscape and holds great promise for “deleting” diseases from human bodies.…
-- بیشتر بخوانید -- - اردیبهشت- 1396 -25 اردیبهشت
Mutation not genetic modification could revive EU bioscience
Mutation not genetic modification could revive EU bioscience A “LANDMARK opinion” from the European Court of Justice on the definition of genetically modified organisms could…
-- بیشتر بخوانید --
